Jazz Pharmaceuticals

Jazz Pharmaceuticals to Acquire Chimerix for $935 Million

Ireland’s Jazz Pharmaceuticals signed an agreement to acquire its compatriot Chimerix for approximately $935 million. The transaction is expected to close in the second quarter of 2025.

Jazz Buys the UK’s GW Pharma

Ireland-based multinational drug company Jazz Pharmaceuticals is to buy UK biopharma GW Pharma for $7.2 billion, creating a leader in neuroscience. The boards of directors of both companies have unanimously approved the deal, which is expected to close in the second quarter, subject to customary conditions and regulatory approvals.

Jazz Pharmaceuticals Buys US Biotech Cavion